Combination of inulin-shellac as a unique coating formulation for design of co-lonic delivery dosage form of ibuprofen

International Journal of Research in Pharmaceutical Sciences

Volumn 3, Issue 1, 2012, Pages 17-23

  Rachmawati, Heni ^a   Mudhakir, Diky ^a   Kusuma, Janti ^a  

^a BANDUNG INSTITUTE OF TECHNOLOGY   (Indonesia)

Author keywords

Ibuprofen; Inulin; Microbe dependent colonic release; Pellet; Pharmacokinetic profile; Shellac

Indexed keywords

IBUPROFEN; INULIN; SHELLAC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG PELLET; NONHUMAN; RABBIT;

EID: 84857700597     PISSN: None     EISSN: 09757538     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Anekant, J., Yashwant, G., and Sanjay, K. J. 'Perspectives of Biodegradable Natural Polysaccharides for SiteSpecific Drug Delivery to the Colon'. Journal of Pharmacology and Pharmaceutical Science, vo.10, no. 1, 2007 pp. 86-128.
2. Ashford, M., Fell, J.T., Attwood, D. and Woodhead, P.J. 'An In-vitro Investigation into the Suitability of pH Dependent Polymers for Colonic Targeting'. International Journal of Pharmaceutics, vol. 91, no. 2-3, 1993a pp. 241-245.
3. Ashford, M., Fell, J.T., Attwood, D., Sharma, H., and Woodhead, P.J. 'An In vivo Investigation into the Suitability of pH-dependent Polymers for Colonic Targeting'. International Journal of Pharmaceutics, vol. 95, no. 1-3, 1993b pp. 193-199.
4. Basit AW. 'Advances in colonic drug delivery'. Drugs, vol.65, 2005 pp. 1991-2007.
5. Cavalcanti OA, Van den Mooter G, Caramico-Soares I, Kinget R. 'Polysaccharides as excipients for colon-specific coatings. Permeability and swelling proper-ties of casted films'. Drug Development and Industrial Pharmacy, vol. 28, 2002 pp. 157-164.
6. Coviello, T., Antonio, P., Mario, G., Pietro, M., Gian-franco B., Franco A. Scleroglucan.'A Versatile Poly-saccharide for Modified Drug Delivery'. Molecules, vol. 10, 2005 pp. 6-33.
7. Dysseler, B.S., Hoffen, M.J. 'Inulin, an alternative dietary fiber. Properties and quantitative analysis'. European Journal of Clinical Nutrition, vol. 49, 1995 pp. S145-S152.
8. Gibson, G.R., and Roberfroid, M. R. 'Dietary modulation of the human colonic microflora, introducing the concept of prebiotics'. Journal of Nutrion, vol.125, 1995 pp. 1401-1414.
9. Kibbe A.H. Handbook of Pharmaceutical Excipients (Ed. A. H. Kibbe), 3rd ed., Pharmaceutical Press, London 2000.
10. Kinget, R., Kalale, W., Vervoort, L., and Van den Mooter, G. 'Colonic drug targeting'. Journal of Drug Targeting, vol. 6, 1998 pp. 129-149.
11. Li, S.P., Feld, K.M. and Kowarski, C.R. 'The Effect of Po-lymer Coating Systems on the Preparation, Tableting, and Dissolution Properties of Sustained-release Drug Pellets'. Drug Development and Industrial Pharmacy, vol. 23, no. 7, 1997 pp. 623-631.
12. McKeller, R.C., Modler, H.W. 'Metabolism of fructooli-gosaccharides by Biffidobacteriumspp'. Applied Microbiology and Biotechnolology, vol. 31, 1989 pp. 537-541.
13. Rubinstein A. 'Approaches and opportunities in colon specific drug delivery'. Critical Review of Therapeutic Drug Carrier Sysemt, vol. 12, 1995 pp. 101-149.
14. Van den Mooter G, Samyn C, Kinget R. 'The relation between swelling properties and enzymatic degradation of azo polymers designed for colon-specific drug delivery'. Pharmaceutical Research, vol. 11, no. 12, December, 1994 pp. 1737-1741.
15. ® RS films'. International Journal of Pharmaceutics, vol. 129, 1996 pp. 185-190.
16. Vervoort L, Rambant P, VandenMooter G, Augustijns P, Kinget R. 'Inulin hydrogels.II. In vitro degradation study'. International Journal of Pharmaceutics, vol. 172, 1998 pp. 137-145.
17. Wang, X., Gibson, G.R. 'Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine'. Journal of Applied Bacterology, vol. 75, 1993 pp. 373-380.
18. Wong, D., Larrabee, S., Clifford, K., Tremblay, J. and Friend, D.R. 'USP Dissolution Apparatus III (Reciprocating Cylinder) for Screening of Guar-based Colonic Delivery Formulations'. Journal of Controlled Release, vol. 47, no. 2, 1997 pp. 173-179.